Even Short-Term Telmisartan Treatment Ameliorated Insulin Resistance But Had No Influence on Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels in Hypertensive Patients with Metabolic Syndrome

Metabolic Syndrome and Related Disorders, Ahead of Print.


http://bit.ly/2D13mMX